Scarica l'app Stockscreener
525.82
0.21%
1.12
Dopo l'orario di chiusura:
530.00
4.18
+0.79%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché UTHR Giù?
Forum
Previsione
Frazionamento azionario
United Therapeutics Corp Borsa (UTHR) Ultime notizie
United Therapeutics Corp (UTHR) Valuation: PE, PB & Fair Value Analysis - TradingKey
United Therapeutics CEO Rothblatt sells $5 million in shares - Investing.com
United Therapeutics (UTHR) CEO exercises options, sells 9,500 shares - Stock Titan
Form 4 United Therapeutics Corporation For: 27 July By Investing.com - Investing.com Canada
United Therapeutics CEO Rothblatt sells $5.05 million in stock - Investing.com
United Therapeutics (UTHR) CEO sells 9,500 shares after option exercise - Stock Titan
United Therapeutics Corporation (UTHR) Stock Analysis: A Healthier Future with 25.5% Potential Upside - DirectorsTalk Interviews
United Therapeutics Corp (UTHR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
UTHR|United Therapeutics Corp|Price:528.470|Chg%:-1.060 - TradingKey
United Therapeutics Corp (NASDAQ: UTHR) CEO trades 9,500 shares in 10b5-1 plan - Stock Titan
United Therapeutics Corp. (UTHR) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Form 4 United Therapeutics Corporation For: 24 July By Investing.com - Investing.com South Africa
United Therapeutics Corp. (UTHR) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
United Therapeutics Director Christopher Patusky Awarded Stock Options and Common Shares in Annual Equity Grant - Kalkine Media
United Therapeutics Director Christopher Causey Awarded Stock Options and Common Shares in Annual Equity Compensation - Kalkine Media
United Therapeutics Director Louis Sullivan Updates Stock Holdings and Receives Annual Stock Option Grant - Kalkine Media
United Therapeutics Corp. (UTHR) Earnings Dates, Call Summary & Reports - TipRanks
Form 4 United Therapeutics Corporation For: 23 July By Investing.com - Investing.com South Africa
Form 4 United Therapeutics Corporation For: 23 July - Investing.com India
United Therapeutics CEO Rothblatt sells $5 million in shares By Investing.com - Investing.com Canada
United Therapeutics Corporation (UTHR) Stock Price, News, Quote & History - Yahoo! Finance Canada
United Therapeutics (UTHR) grants director Victor Dzau RSUs and stock options - Stock Titan
United Therapeutics (UTHR) director Victor Dzau submits initial Form 3 - Stock Titan
United Therapeutics (UTHR) awards RSUs and stock options to director - Stock Titan
United Therapeutics Corp (UTHR) awards RSUs and options to director - Stock Titan
United Therapeutics (UTHR) awards director 760 restricted stock units - Stock Titan
United Therapeutics (UTHR) awards 760 RSUs to board director Judy D. Olian - Stock Titan
United Therapeutics (UTHR) director gets RSU and stock option grants - Stock Titan
United Therapeutics (UTHR) awards RSUs and stock options to director Nilda Mesa - Stock Titan
United Therapeutics (UTHR) grants director 2,380 stock options at $527.07 - Stock Titan
United Therapeutics (UTHR) awards 2,380 stock options to director Causey - Stock Titan
United Therapeutics (UTHR) awards 2,380 stock options to board director - Stock Titan
United Therapeutics (UTHR) awards 760 RSUs in annual director grant - Stock Titan
United Therapeutics (NASDAQ: UTHR) grants stock units and options to director Kurzweil - Stock Titan
United Therapeutics Corp (UTHR) CEO exercises options, sells 9,500 shares - Stock Titan
United Therapeutics Boosts Board to 13 Members with Appointment of Esteemed Medical Expert Victor Dzau, M.D. - Kalkine Media
United Therapeutics (NASDAQ: UTHR) appoints Victor Dzau to board - Stock Titan
After 12 years as NAM president, Victor Dzau joins United Therapeutics board - Stock Titan
United Therapeutics Corp. (UTH) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
United Therapeutics to report Q2 2026 results on August 5 - scanx.trade
United Therapeutics Corporation to Report Second Quarter 2026 Financial Results Before Market Open on Wednesday, August 5, 2026 - Yahoo Finance
ETFs Investing in United Therapeutics Corporation Stocks - TradingView
MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ - Stocktwits
Form 4 United Therapeutics Corporation For: 21 July By Investing.com - Investing.com South Africa
United Therapeutics CEO Rothblatt sells $5.05m in stock By Investing.com - Investing.com Nigeria
United Therapeutics CEO Rothblatt sells $5.05m in stock - Investing.com
United Therapeutics (UTHR) CEO executes 9,500-share option exercise and sale - Stock Titan
Boehringer Alleges United Therapeutics Poached Staff, Secrets - Law360
United Therapeutics (NASDAQ: UTHR) CEO sells 9,500 shares under 10b5-1 plan - Stock Titan
Lobbying Update: $80,000 of UNITED THERAPEUTICS CORPORATION lobbying was just disclosed - Quiver Quantitative
United Therapeutics Corp (UTHR) - MSN
United Therapeutics CEO Rothblatt sells $5.04 million in company shares By Investing.com - Investing.com Nigeria
United Therapeutics CEO Rothblatt sells $5.04 million in company shares - Investing.com
Form 4 United Therapeutics Corporation For: 17 July By Investing.com - Investing.com Canada
United Therapeutics Corp (UTHR) CEO trades options and common shares - Stock Titan
United Therapeutics CEO Rothblatt sells $5.04m in UTHR shares By Investing.com - Investing.com South Africa
United Therapeutics CEO Rothblatt sells $5.04m in UTHR shares - Investing.com
Form 4 United Therapeutics Corporation For: 16 July By Investing.com - Investing.com Canada
0.34%
2.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):